For people with Lyme disease who have digestion problems aggravated by antibiotics, poor diet, and gut inflammation
by Greg Lee
Have you heard the story of the Dutch boy who sticks his finger in a dike? He plugs a small trickle of water which would have turned into a stream, then a torrent, and then a flood which would have washed away the town. He saves his town by acting quickly and averting a disaster.
How is a trickle of water in a damaged dike similar to a person with a leaky gut?
Just like water that seeps through a dike, a leaky gut can let food, pathogens, and toxins out of the intestines and into the blood
People with leaky gut have toxic pathogens which live in and alter the lining of the intestines. A diet high in inflammatory foods can also increase the holes in the lining of the intestines¹. Pathogens which open up holes in the intestines can come from eating food contaminated with parasites or other infections². Alcoholics with increased bacterial lipopolysaccharides³ and children with autism have a high incidence of leaky gut⁴. People with Lyme disease who receive antibiotic treatment can have their healthy gut microbes killed off which allows unhealthy germs like Clostridium difficile and drug resistant microbes⁵ to grow and create holes in the intestine walls. Pathogenic toxins from mold⁶ can also irritate the gut. These irritants can lead to wide range of local and systemic symptoms.
People with leaky gut have toxic pathogens which live in and alter the lining of the intestines. A diet high in inflammatory foods can also increase the holes in the lining of the intestines¹. Pathogens which open up holes in the intestines can come from eating food contaminated with parasites or other infections². Alcoholics with increased bacterial lipopolysaccharides³ and children with autism have a high incidence of leaky gut⁴. People with Lyme disease who receive antibiotic treatment can have their healthy gut microbes killed off which allows unhealthy germs like Clostridium difficile and drug resistant microbes⁵ to grow and create holes in the intestine walls. Pathogenic toxins from mold⁶ can also irritate the gut. These irritants can lead to wide range of local and systemic symptoms.
Leaky gut syndrome can produce a wide range of symptoms
Inflammatory compounds irritate the lining of the intestines which leads to an increased number of leaks in the intestinal walls. This increases symptoms of bloating, distention, and pain in the gut⁷. These leaks allow larger food particles, pathogens, toxins, and inflammatory compounds to seep into the blood stream⁸. As these compounds circulate through the body, they can also lead to increased symptoms of allergic reactions, heart problems, metabolic weight gain⁹, joint pain and inflammation¹⁰, migraines¹¹, and depression¹². In response to these compounds coming into the blood stream, the immune system mounts a response.
Inflammatory compounds irritate the lining of the intestines which leads to an increased number of leaks in the intestinal walls. This increases symptoms of bloating, distention, and pain in the gut⁷. These leaks allow larger food particles, pathogens, toxins, and inflammatory compounds to seep into the blood stream⁸. As these compounds circulate through the body, they can also lead to increased symptoms of allergic reactions, heart problems, metabolic weight gain⁹, joint pain and inflammation¹⁰, migraines¹¹, and depression¹². In response to these compounds coming into the blood stream, the immune system mounts a response.
The immune system sees the intestinal compounds that are seeping into the blood as invaders to be attacked
In response to pathogenic toxins leaking from the intestines, the immune system produces multiple inflammatory compounds: Transforming growth factor beta-1 (TGF Beta-1), Matrix metallopeptidase 9 (MMP-9), Interleukin-1 beta (IL-1β), and Plasminogen activator inhibitor-1 (PAI-1)¹³. These inflammatory compounds affect multiple systems of the body. Because of the inflammatory compounds that become elevated in people with Lyme disease or co-infections, they are at greater risk of leaky gut. In a study on Lyme disease patients, Tumor necrosis factor alpha (TNFα) and Interleukin-13 (IL-13) were found to be elevated in different phases of infection¹⁴. TNFα has also been found to be elevated in Bartonella infections¹⁵, mice infected with Babesia¹⁶, mice receiving Rocky Mountain Spotted Fever antigens¹⁷, Ehrlichia infections¹⁸, and in Brucellosis patients¹⁹. Both TNFα and IL-13 have a direct effect on increasing intestinal lining leakage²⁰. Unfortunately, western medicine lacks a way to accurately diagnose and to treat leaky gut syndrome.
If medications are not known to be effective, what else can help you to heal leaky gut syndrome?
Here are four strategies for helping to heal leaky gut syndrome
There are several steps to healing leaky gut
● Neutralize or drain toxins, inflammatory compounds, and accumulated congestion which aggravate the intestinal lining and different areas of the body (liver, gall bladder, and brain)
● Heal the leaks in the intestinal walls
● Kill pathogens embedded in intestines
● Improve diet to reduce / eliminate inflammatory foods, xeno-estrogen meats, and / or pathogens
● Neutralize or drain toxins, inflammatory compounds, and accumulated congestion which aggravate the intestinal lining and different areas of the body (liver, gall bladder, and brain)
● Heal the leaks in the intestinal walls
● Kill pathogens embedded in intestines
● Improve diet to reduce / eliminate inflammatory foods, xeno-estrogen meats, and / or pathogens
Healing Leaky Gut Strategy #1: Neutralize toxins and drain congestion and inflammation
Toxins from parasites and other germs trigger the body to produce inflammation. Neutralizing the toxins helps to reduce the irritation in the intestines. There are several herbs and essential oils that neutralize toxins as well as reduce the inflammatory compounds which aggravate leaky gut symptoms.
Toxins from parasites and other germs trigger the body to produce inflammation. Neutralizing the toxins helps to reduce the irritation in the intestines. There are several herbs and essential oils that neutralize toxins as well as reduce the inflammatory compounds which aggravate leaky gut symptoms.
Scutellaria baicalensis, Chinese name: Huang Qin²¹, contains multiple compounds that neutralize bacterial endotoxins also know as lipopolysaccharides in animal and lab studies. These compounds also inhibit TNFα: baicalein, baicalin²², flavonoids²³, wogonin²⁴, and wogonoside²⁵. Baicalein²⁶ and scutellaria²⁷ repaired the inflammatory damage caused by IL-13 in mouse studies.
Licorice, Chinese name: Gan Cao, also contains multiple anti-toxin and anti-inflammatory compounds including: 18β-Glycyrrhetinic acid²⁸, flavonoids, glycyrrhizin acid²⁹, and licochalcone Av³⁰. All these compounds inhibit TNFα and the latter three also inhibit IL-13 in animal studies. One of the most recommended forms is deglycyrrhizinated licorice for treating leaky gut³¹.
Nutmeg, Chinese name: Rou Dou Kou, has been used traditionally for treating diarrhea, dysentery, abdominal pain, fullness, distention, and coldness. It has also been effective in combination with other herbs in treating ulcerative colitis and infantile diarrhea in China³². Nutmeg also contains neolignans³³, Malabaricone C³⁴, and Macelignan³⁵ which inhibit endotoxin inflammation in animal and lab studies. Macelignan also inhibits IL-13 and TNF alpha in a rat study³⁶.
Lavender essential oil has been used traditionally to treat gastrointestinal disorders. In animal studies, lavender oil inhibits TNFα³⁷ and IL-13³⁸. In a lab study, lavender oil inhibited the effects of endotoxins on human monocytes³⁹. In addition to herbs and supplements, Frequency Specific Microcurrent can help to neutralize toxins and inflammation.
Frequency Specific Microcurrent uses low level electrical currents to neutralize toxins, lower inflammation, and reduce allergic reactions⁴⁰. It also uses frequencies to target the different parts of the digestion system like the small intestine (22), large intestine (85), and the iliocecal valve (31) that can be affected by leaky gut. In addition to removing toxins and inflammation, the leaks need to be sealed up.
Healing Leaky Gut Strategy #2: Heal the leaks in the intestinal walls
There are supplements and herbs which help to plug the leaks and protect the walls of the intestines. These remedies help to plug up the holes in the intestinal barrier, provide healthy microbes to add another layer of protection for the intestines, and reduce toxicity in human and animals studies.
There are supplements and herbs which help to plug the leaks and protect the walls of the intestines. These remedies help to plug up the holes in the intestinal barrier, provide healthy microbes to add another layer of protection for the intestines, and reduce toxicity in human and animals studies.
Probiotics are healthy bacteria and microbes which digest food and provide protection to the walls of the intestines. In human⁴¹ and animal subjects, probiotics including Streptococcus thermophilus and Lactobacillus acidophilus⁴² have improved intestinal wall permeability in irritable bowel syndrome studies. Animals in these studies also showed a decrease in levels of endotoxins or lipopolysaccharides⁴³.
Arabinogalactan from larch bark helps to feed healthy probiotic bacteria and impede the growth of pathogenic organisms in the intestines⁴⁴. This supplement also reduced ammonia in human fecal samples⁴⁵.
L-Glutamine in multiple animal studies had a range of beneficial effects on healing damage to the intestines⁴⁶ of the type caused by TNFα and IL-13. In a pig study, this supplement enhanced the expression of tight junction protein expression in the intestines⁴⁷. In a mouse study, glutamine provided significant protection against gut injury and inflammation⁴⁸. In a rat study, glutamine repaired intestinal damage⁴⁹. In a human study, glutamine significantly attenuates the IgA and IgM responses to gram negative endotoxins. Up to 24 patients showed significant clinical improvement or remission 0 – 14 months after taking glutamine, n-acetyl cysteine, and zinc along with a leaky gut diet⁵⁰.
Zinc helps also with repairing intestinal permeability in study with Crohn’s patients⁵¹.
Melatonin in one rat study, significantly reduced ethanol or wine induced intestinal permeability.⁵² In another rat study, melatonin prevented gut barrier dysfunction, reduced bacterial translocation, and decreased early mortality⁵³. In another mouse study, melatonin limited intestinal damage and permeability and preserved aspects of mitochondrial function⁵⁴.
Honeysuckle flowers, Chinese name: Jin Yin Hua regulated gut flora distribution and gut permeabiltiy in one rat study⁵⁵. This herb is also highly effective at neutralizing endotoxins in other animal studies.
Curcumin derived from turmeric is an immunomodulator, anti-inflammatory, and oxidative stress reducing compound. It relieves irritable bowel symptoms in animal studies⁵⁶. Unfortunately, curcumin is not well absorbed through the intestines. Fortunately, liposomal curcumin in a cow study had greater local tissue absorption⁵⁷, which would suggest that using enteric coated capsules or a retention enema for more effective delivery into the intestines.
Agaricus mushroom combined with selenium protected against heat stress ileum permeability in a rat study⁵⁸. As the intestinal barrier gets repaired, the damaging microbes need to be eliminated.
Healing Leaky Gut Strategy #3: Kill pathogens that are embedded in the intestinal walls
Many different pathogens can increase intestinal wall permeability like E. Coli⁵⁹, Salmonella enteritidis⁶⁰, Streptococcus pneumoniae⁶¹, Hafnia alvei, Pseudomonas aeruginosa, Morganella morganii, Pseudomonas putida, Citrobacter koseri, and Klebsiella pneumoniae⁶². The food borne infection Listeria monocytogenes can produce symptoms of gastroenteritis, sepsis, and meningitis. This bacteria is capable of invading the blood through the epithelial lining of the intestines⁶³. Multiple remedies have been helpful are reducing bloating, pain, and nausea from leaky gut.
Many different pathogens can increase intestinal wall permeability like E. Coli⁵⁹, Salmonella enteritidis⁶⁰, Streptococcus pneumoniae⁶¹, Hafnia alvei, Pseudomonas aeruginosa, Morganella morganii, Pseudomonas putida, Citrobacter koseri, and Klebsiella pneumoniae⁶². The food borne infection Listeria monocytogenes can produce symptoms of gastroenteritis, sepsis, and meningitis. This bacteria is capable of invading the blood through the epithelial lining of the intestines⁶³. Multiple remedies have been helpful are reducing bloating, pain, and nausea from leaky gut.
Ozonated oils have antifungal and broad antibacterial properties. Ozonated sesame oil inhibited the growth of Candida albicans, Pseudomonas aeruginosa, Staphylococcus aureus, E. coli, and Enterococcus faecalis in a lab study⁶⁴. Patients will take them in capsules, drink them in water or use them in retention enemas. Ozonated oils are often combined with essential oils.
Essential oils also have broad antifungal, antibacterial, and antiparasitic properties. These oils are delivered into the intestines via capsules, retention enemas, and liposomal mixtures.
Artemisia annua essential oil has been shown to inhibit a wide range of pathogens including gram-positive bacteria (Enterococcus, Streptococcus, Staphylococcus, Bacillus, and Listeria spp.), and gram-negative bacteria (Escherichia, Shigella, Salmonella, Haemophilus, Klebsiella, and Pseudomonas spp.) and other microorganisms (Candida, Saccharomyces, and Aspergillus spp.) It also contains the anti-malarial compound artemisinin⁶⁵, which has also been used clinically to treat protozoa infections like Babesia and Leishmaniasis⁶⁶.
Lemongrass, oregano, and bay essential oils inhibited Acinetobacter baumanii, Aeromonas veronii biogroup sobria, Candida albicans, Enterococcus faecalis, Escherichia col, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella enterica subsp. enterica serotype typhimurium, Serratia marcescens and Staphylococcus aureus at less than or equal to 2% (v/v) in another lab study⁶⁷.
Clove essential oil had a marked germicidal effect on Candida albicans. Staphylococcus aureus (five strains), Klebsiella pneumoniae, Pseudomonas aeruginosa, Clostridium perfringens, and Escherichia coli at 0.4% (v/v) dispersed in a sugar solution in a third lab study⁶8. This oil has also been shown to inhibit protozoa infections that can infect the intestines including Leishmaniasis⁶⁹ and Giardia⁷⁰ in lab studies. In addition to purging pathogens, dietary improvements help to maintain and improve intestinal wall integrity.
Healing Leaky Gut Strategy #4: Improve diet to reduce / eliminate intestinal leaks and increase anti-inflammatory foods
Reduce or eliminate foods with gluten like wheat, rye, and barley. In one study, gliadin which is found in gluten increased intestinal permeability which was correlated with depression⁷¹.
Reduce foods made with commonly used industrial food additives including: glucose, salt, emulsifiers, organic solvents, microbial transglutaminase, and nanoparticles which increase intestinal permeability⁷².
Avoid taking ascorbic acid in combination with aspirin which increases the excretion of lactulose in a human study, a sign of increased intestinal permeability⁷³
Reduce alcohol consumption⁷⁴. Dietary changes can also help with reducing inflammatory compounds which can injure the gut.
The Mediterranean diet can help with reducing systemic inflammation.⁷⁵ It consists of anti-oxidant rich fruits and vegetables, and whole grains, preferably without gluten. This diet also recommends eating legumes and nuts, replacing butter with healthy fats, such as olive oil, using herbs and spices instead of salt to flavor foods, limiting red meat to no more than a few times a month, and eating fish and poultry at least twice a week⁷⁶. This diet can help to limit systemic TNFα and its impact on intestinal permeability⁷⁷. A multipronged strategy helps you to repair the damage in a leaky gut.
Remedies, treatments, and a healthy diet can help to reduce symptoms of leaky gut caused by antibiotics, intestinal pathogens, and poor diet
Just like plugging a leaky dike, a combination of herbs, supplements, Frequency Specific Microcurrent treatment, and dietary modifications can help to repair the holes in the intestines and reverse the discomfort of leaky gut syndrome. Since some of these remedies and treatments require specialized training, work with a Lyme literate Chinese medicine practitioner to develop a proper, safe, and effective strategy for your condition.
Just like plugging a leaky dike, a combination of herbs, supplements, Frequency Specific Microcurrent treatment, and dietary modifications can help to repair the holes in the intestines and reverse the discomfort of leaky gut syndrome. Since some of these remedies and treatments require specialized training, work with a Lyme literate Chinese medicine practitioner to develop a proper, safe, and effective strategy for your condition.
– Greg
P.S. Do you have experiences where treatments or remedies improved your abdominal bloating, pain, and distention from Lyme disease leaky gut? Tell us about it.
>> Next step: Come to our evening lecture: Getting Rid of Lyme Disease in Frederick, Maryland on Monday April 6th at 6pm to learn more about treatments, essential oils, herbs, and homeopathic remedies for healing leaku gut from Lyme disease, Bartonella, toxoplasmosis, drug resistant arthritis, managing weight issues caused by toxins, reducing brain overwhelm, Epstein-Barr virus, adenovirus, brucellosis, Babesia, mold, parasites, abnormal fatigue, and pain. https://goodbyelyme.com/events/get_rid_lyme
1. Del Piano M, Balzarini M, Carmagnola S, Pagliarulo M, Tari R, Nicola S, Deidda F, Pane M. Assessment of the capability of a gelling complex made of tara gum and the exopolysaccharides produced by the microorganism Streptococcus thermophilus ST10 to prospectively restore the gut physiological barrier: a pilot study. J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S56-61. doi: 10.1097/MCG.0000000000000254. https://www.ncbi.nlm.nih.gov/pubmed/25291130
2. Del Piano, Mario, Marco Balzarini, Stefania Carmagnola, Michela Pagliarulo, Roberto Tari, Stefania Nicola, Francesca Deidda, and Marco Pane. “Assessment of the Capability of a Gelling Complex Made of Tara Gum and the Exopolysaccharides Produced by the Microorganism Streptococcus Thermophilus ST10 to Prospectively Restore the Gut Physiological Barrier: A Pilot Study.” Journal of Clinical Gastroenterology 48 Suppl 1 (December 2014): S56–61. doi:10.1097/MCG.0000000000000254. https://www.ncbi.nlm.nih.gov/pubmed/25291130
3. Ilan Y. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18(21): 2609-2618 Available from: URL: https://www.wjgnet.com/1007-9327/full/v18/i21/2609.htm DOI: https://dx.doi.org/10.3748/wjg.v18.i21.2609 https://www.wjgnet.com/1007-9327/pdf/v18/i21/2609.pdf
4. Samsam M, Ahangari R, Naser SA. Pathophysiology of autism spectrum disorders:
revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol. 2014 Aug 7;20(29):9942-51. doi: 10.3748/wjg.v20.i29.9942. https://www.ncbi.nlm.nih.gov/pubmed/25110424
5. Wyatt, D. Leaky Gut Syndrome: Modern Epidemic with an Ancient Solution? Townshend Letter. June 2014. https://www.townsendletter.com/June2014/leaky0614.html
6. Mezzelani A, Raggi ME, Marabotti A, Milanesi L. Ochratoxin A as possible factor trigging autism and its male prevalence via epigenetic mechanism. Nutr Neurosci. 2015 Jan 17. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/25597866
7. Kennedy, Paul J, John F Cryan, Timothy G Dinan, and Gerard Clarke. “Irritable Bowel Syndrome: A Microbiome-Gut-Brain Axis Disorder?” World Journal of Gastroenterology : WJG 20, no. 39 (October 21, 2014): 14105–25. doi:10.3748/wjg.v20.i39.14105. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202342/
8. Del Piano, Mario, Marco Balzarini, Stefania Carmagnola, Michela Pagliarulo, Roberto Tari, Stefania Nicola, Francesca Deidda, and Marco Pane. “Assessment of the Capability of a Gelling Complex Made of Tara Gum and the Exopolysaccharides Produced by the Microorganism Streptococcus Thermophilus ST10 to Prospectively Restore the Gut Physiological Barrier: A Pilot Study.” Journal of Clinical Gastroenterology 48 Suppl 1 (December 2014): S56–61. doi:10.1097/MCG.0000000000000254. https://www.ncbi.nlm.nih.gov/pubmed/25291130
9. Rapin, Jean Robert, and Nicolas Wiernsperger. “Possible Links between Intestinal Permeability and Food Processing: A Potential Therapeutic Niche for Glutamine.” Clinics (São Paulo, Brazil) 65, no. 6 (June 2010): 635–43. doi:10.1590/S1807-59322010000600012. https://www.ncbi.nlm.nih.gov/pubmed/20613941
10. Orchard, Timothy R. “Management of Arthritis in Patients with Inflammatory Bowel Disease.” Gastroenterology & Hepatology 8, no. 5 (May 2012): 327–29. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424429/
11. van Hemert S, Breedveld AC, Rovers JM, Vermeiden JP, Witteman BJ, Smits MG, de Roos NM. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Front Neurol. 2014 Nov 21;5:241. doi: 10.3389/fneur.2014.00241. eCollection 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240046/
12. Karakuła-Juchnowicz H, Szachta P, Opolska A, Morylowska-Topolska J, Gałęcka M, Juchnowicz D, Krukow P, Lasik Z. The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders. Nutr Neurosci. 2014 Sep 30. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/25268936
13. Shoemaker, R. The Biotioxin Pathway. https://www.survivingmold.com/diagnosis/the-biotoxin-pathway
14. Glickstein L, Moore B, Bledsoe T, Damle N, Sikand V, Steere AC. Inflammatory Cytokine Production Predominates in Early Lyme Disease in Patients with Erythema Migrans . Infection and Immunity. 2003;71(10):6051-6053. doi:10.1128/IAI.71.10.6051-6053.2003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201073/
15. Buhner, Stephen H., Healing Lyme Disease Coinfections, Complementary and Holistic Treatments for Bartonella and Mycoplasma. Rochester: Healing Arts Press. 2013. Print. p. 342.
16. Hemmer RM, Ferrick DA, Conrad PA. Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1. Parasitol Res. 2000 Feb;86(2):121-8. https://www.ncbi.nlm.nih.gov/pubmed/10685843
17. Gong W, Xiong X, Qi Y, Jiao J, Duan C, Wen B. Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice. Vaccine. 2014 Apr 11;32(18):2027-33. doi: 10.1016/j.vaccine.2014.02.057. Epub 2014 Feb 28. https://www.ncbi.nlm.nih.gov/pubmed/24582636
18. Ismail N, Walker DH, Ghose P, Tang YW. Immune mediators of protective and pathogenic immune responses in patients with mild and fatal human monocytotropic ehrlichiosis. BMC Immunol. 2012 May 21;13:26. doi: 10.1186/1471-2172-13-26. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517396/
19. Feldman KE, Loriaux PM, Saito M, Tuero I, Villaverde H, Siva T, Gotuzzo E, Gilman RH, Hoffmann A, Vinetz JM. Ex vivo innate immune cytokine signature of enhanced risk of relapsing brucellosis. PLoS Negl Trop Dis. 2013 Sep 5;7(9):e2424. doi: 10.1371/journal.pntd.0002424. eCollection 2013. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764229/
20. Odenwald MA, Turner JR. Intestinal permeability defects: Is it time to treat? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2013;11(9):1075-1083. doi:10.1016/j.cgh.2013.07.001. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758766/
21. Shin HS1, Bae MJ1, Jung SY1, Shon DH2. Preventive effects of skullcap (Scutellaria baicalensis) extract in a mouse model of food allergy. J Ethnopharmacol. 2014 May 14;153(3):667-73. doi: 10.1016/j.jep.2014.03.018. Epub 2014 Mar 15. https://www.ncbi.nlm.nih.gov/pubmed/24637193
22. Woo et al., “Differential Inhibitory Effects of Baicalein and Baicalin on LPS-Induced Cyclooxygenase-2 Expression through Inhibition of C/EBPbeta DNA-Binding Activity.” Immunobiology. 2006;211(5):359-68. Epub 2006 Mar 29. https://www.ncbi.nlm.nih.gov/pubmed/16716805
23. Kim, Jin A., Arulkumar Nagappan, Hyeon Soo Park, Venu Venkatarame Gowda Saralamma, Gyeong Eun Hong, Silvia Yumnam, Ho Jeong Lee, et al. “Proteome Profiling of Lipopolysaccharide Induced L6 Rat Skeletal Muscle Cells Response to Flavonoids from Scutellaria Baicalensis Georgi.” BMC Complementary and Alternative Medicine 14 (2014): 379. doi:10.1186/1472-6882-14-379. https://www.ncbi.nlm.nih.gov/pubmed/25287937
24. Huang, Guan-Cheng, Jyh-Ming Chow, Shing-Chuan Shen, Liang-Yo Yang, Cheng-Wei Lin, and Yen-Chou Chen. “Wogonin but Not Nor-Wogonin Inhibits Lipopolysaccharide and Lipoteichoic Acid-Induced iNOS Gene Expression and NO Production in Macrophages.” International Immunopharmacology 7, no. 8 (August 2007): 1054–63. doi:10.1016/j.intimp.2007.04.001. https://www.ncbi.nlm.nih.gov/pubmed/17570322
25. Yang, Yao-Zhi, You-Zhi Tang, and Ya-Hong Liu. “Wogonoside Displays Anti-Inflammatory Effects through Modulating Inflammatory Mediator Expression Using RAW264.7 Cells.” Journal of Ethnopharmacology 148, no. 1 (June 21, 2013): 271–76. doi:10.1016/j.jep.2013.04.025. https://www.ncbi.nlm.nih.gov/pubmed/23612420
26. Mabalirajan, Ulaganathan, Tanveer Ahmad, Rakhshinda Rehman, Geeta Devi Leishangthem, Amit Kumar Dinda, Anurag Agrawal, Balaram Ghosh, and Surendra Kumar Sharma. “Baicalein Reduces Airway Injury in Allergen and IL-13 Induced Airway Inflammation.” PloS One 8, no. 4 (2013): e62916. doi:10.1371/journal.pone.0062916. https://www.ncbi.nlm.nih.gov/pubmed/23646158
27. Shin, Hee Soon, Min-Jung Bae, Sun Young Jung, and Dong-Hwa Shon. “Preventive Effects of Skullcap (Scutellaria Baicalensis) Extract in a Mouse Model of Food Allergy.” Journal of Ethnopharmacology 153, no. 3 (May 14, 2014): 667–73.
doi:10.1016/j.jep.2014.03.018. https://www.ncbi.nlm.nih.gov/pubmed/24637193
28. Kong, Song-Zhi, Hai-Ming Chen, Xiu-Ting Yu, Xie Zhang, Xue-Xuan Feng, Xin-Huang Kang, Wen-Jie Li, Na Huang, Hui Luo, and Zi-Ren Su. “The Protective Effect of 18β-Glycyrrhetinic Acid against UV Irradiation Induced Photoaging in Mice.” Experimental Gerontology 61 (January 2015): 147–55. doi:10.1016/j.exger.2014.12.008. https://www.ncbi.nlm.nih.gov/pubmed/25498537
29. Liu, Zhao, Ju-Ying Zhong, Er-Ning Gao, and Hong Yang. “[Effects of glycyrrhizin acid and licorice flavonoids on LPS-induced cytokines expression in macrophage].” Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica 39, no. 19 (October 2014): 3841–45. https://www.ncbi.nlm.nih.gov/pubmed/25612451
30. Fontes, Lívia Beatriz Almeida, Débora Dos Santos Dias, Lara Soares Aleixo de Carvalho, Harleson Lopes Mesquita, Lívia da Silva Reis, Alyria Teixeira Dias, Ademar A. Da Silva Filho, and José Otávio do Amaral Corrêa. “Immunomodulatory Effects of Licochalcone A on Experimental Autoimmune Encephalomyelitis.” The Journal of Pharmacy and Pharmacology 66, no. 6 (June 2014): 886–94. doi:10.1111/jphp.12212. https://www.ncbi.nlm.nih.gov/pubmed/24447171
31. “Deglycyrrhizinated Licorice (DGL): Gut Benefits and Beyond.” The Huffington Post. Accessed March 17, 2015. https://www.huffingtonpost.com/julie-chen-md/dgl-supplements_b_2976260.html.
32. Chen, John K., and Tina T. Chen. 2004. Chinese Medical Herbology and Pharmacology. City of Industry CA: Art of Medicine Press, Inc., pp. 999 – 1001.
33. Cao, Gui-Yun, Xiu-Wei Yang, Wei Xu, and Fei Li. “New Inhibitors of Nitric Oxide Production from the Seeds of Myristica Fragrans.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 62 (December 2013): 167–71. doi:10.1016/j.fct.2013.08.046. https://www.ncbi.nlm.nih.gov/pubmed/23994084
34. Kang, Jungwon, Nara Tae, Byung Sun Min, Jongseon Choe, and Jeong-Hyung Lee. “Malabaricone C Suppresses Lipopolysaccharide-Induced Inflammatory Responses via Inhibiting ROS-Mediated Akt/IKK/NF-κB Signaling in Murine Macrophages.” International Immunopharmacology 14, no. 3 (November 2012): 302–10. doi:10.1016/j.intimp.2012.08.006. https://www.ncbi.nlm.nih.gov/pubmed/22917708
35. Han, Young Sun, Myung-Suk Kim, and Jae-Kwan Hwang. “Macelignan Inhibits Histamine Release and Inflammatory Mediator Production in Activated Rat Basophilic Leukemia Mast Cells.” Inflammation 35, no. 5 (October 2012): 1723–31. doi:10.1007/s10753-012-9490-1. https://www.ncbi.nlm.nih.gov/pubmed/19483320
36. Han YS, Kim MS, Hwang JK. Macelignan inhibits histamine release and inflammatory mediator production in activated rat basophilic leukemia mast cells. Inflammation. 2012 Oct;35(5):1723-31. doi: 10.1007/s10753-012-9490-1. https://www.ncbi.nlm.nih.gov/pubmed/22729280
37. Baker, J., K. Brown, E. Rajendiran, A. Yip, D. DeCoffe, C. Dai, E. Molcan, et al. “Medicinal Lavender Modulates the Enteric Microbiota to Protect against Citrobacter Rodentium-Induced Colitis.” American Journal of Physiology. Gastrointestinal and Liver Physiology 303, no. 7 (October 2012): G825–36. doi:10.1152/ajpgi.00327.2011. https://www.ncbi.nlm.nih.gov/pubmed/22821949
38. Ueno-Iio, Tomoe, Misako Shibakura, Kanayo Yokota, Michinori Aoe, Tomoko Hyoda, Ryoko Shinohata, Arihiko Kanehiro, Mitsune Tanimoto, and Mikio Kataoka. “Lavender Essential Oil Inhalation Suppresses Allergic Airway Inflammation and Mucous Cell Hyperplasia in a Murine Model of Asthma.” Life Sciences 108, no. 2 (July 17, 2014):
109–15. doi:10.1016/j.lfs.2014.05.018. https://www.ncbi.nlm.nih.gov/pubmed/24909715
39. Huang, Mei-Yu, May-Hua Liao, Yang-Kao Wang, Yung-Sheng Huang, and Hsiao-Chuan Wen. “Effect of Lavender Essential Oil on LPS-Stimulated Inflammation.” The American Journal of Chinese Medicine 40, no. 4 (2012): 845–59. doi:10.1142/S0192415X12500632. https://www.ncbi.nlm.nih.gov/pubmed/22809036
40. McMakin C. Frequency Specific Microcurrent in Pain Management. Edinburgh: Churchill Livingstone/Elsevier; 2011.
41. Barbara, Giovanni, Lisa Zecchi, Raffaella Barbaro, Cesare Cremon, Lara Bellacosa, Marco Marcellini, Roberto De Giorgio, Roberto Corinaldesi, and Vincenzo Stanghellini. “Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome.” Journal of Clinical Gastroenterology 46 Suppl (October 2012): S52–55. doi:10.1097/MCG.0b013e318264e918. https://www.ncbi.nlm.nih.gov/pubmed/22955358
42. Ukena, Sya N., Anurag Singh, Ulrike Dringenberg, Regina Engelhardt, Ursula Seidler, Wiebke Hansen, André Bleich, et al. “Probiotic Escherichia Coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity.” PLoS ONE 2, no. 12 (December 12, 2007). doi:10.1371/journal.pone.0001308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110898/
43. Ait-Belgnaoui, Afifa, Henri Durand, Christel Cartier, Gilles Chaumaz, Hélène Eutamene, Laurent Ferrier, Eric Houdeau, Jean Fioramonti, Lionel Bueno, and Vassilia Theodorou. “Prevention of Gut Leakiness by a Probiotic Treatment Leads to Attenuated HPA Response to an Acute Psychological Stress in Rats.” Psychoneuroendocrinology 37, no. 11 (November 2012): 1885–95. doi:10.1016/j.psyneuen.2012.03.024. https://www.ncbi.nlm.nih.gov/pubmed/22541937
44. Bodera, Pawel. “Influence of Prebiotics on the Human Immune System (GALT).” Recent Patents on Inflammation & Allergy Drug Discovery 2, no. 2 (June 2008): 149–53. https://www.ncbi.nlm.nih.gov/pubmed/19076004
45 Robinson, R. R., J. Feirtag, and J. L. Slavin. “Effects of Dietary Arabinogalactan on Gastrointestinal and Blood Parameters in Healthy Human Subjects.” Journal of the American College of Nutrition 20, no. 4 (August 2001): 279–85. https://www.ncbi.nlm.nih.gov/pubmed/11506055
46. Rapin, Jean Robert, and Nicolas Wiernsperger. “Possible Links between Intestinal Permeability and Food Processing: A Potential Therapeutic Niche for Glutamine.” Clinics (São Paulo, Brazil) 65, no. 6 (June 2010): 635–43. doi:10.1590/S1807-59322010000600012. https://www.ncbi.nlm.nih.gov/pubmed/20613941
47. Wang, Hao, Chen Zhang, Guoyao Wu, Yuli Sun, Bin Wang, Beibei He, Zhaolai Dai, and Zhenlong Wu. “Glutamine Enhances Tight Junction Protein Expression and Modulates Corticotropin-Releasing Factor Signaling in the Jejunum of Weanling Piglets.” The Journal of Nutrition 145, no. 1 (January 2015): 25–31. doi:10.3945/jn.114.202515. https://www.ncbi.nlm.nih.gov/pubmed/25527658
48. Peng, Zhanglong, Kechen Ban, Richard A. Wawrose, Adam G. Gover, and Rosemary A. Kozar. “Protection by Enteral Glutamine Is Mediated by Intestinal Epithelial Cell Peroxisome Proliferator-Activated Receptor-Γ During Intestinal Ischemia/Reperfusion.” Shock (Augusta, Ga.) 43, no. 4 (April 2015): 327–33. doi:10.1097/SHK.0000000000000297.
49. Beaufrère, A. M., N. Neveux, P. Patureau Mirand, C. Buffière, G. Marceau, V. Sapin, L. Cynober, and D. Meydinal-Denis. “Long-Term Intermittent Glutamine Supplementation Repairs Intestinal Damage (structure and Functional Mass) with Advanced Age: Assessment with Plasma Citrulline in a Rodent Model.” The Journal of Nutrition, Health
& Aging 18, no. 9 (November 2014): 814–19. doi:10.1007/s12603-014-0468-6. https://www.ncbi.nlm.nih.gov/pubmed/25389959
50. Maes, Michael, and Jean-Claude Leunis. “Normalization of Leaky Gut in Chronic Fatigue Syndrome (CFS) Is Accompanied by a Clinical Improvement: Effects of Age, Duration of Illness and the Translocation of LPS from Gram-Negative Bacteria.” Neuro Endocrinology Letters 29, no. 6 (December 2008): 902–10. https://www.ncbi.nlm.nih.gov/pubmed/19112401
51. Sturniolo, G. C., V. Di Leo, A. Ferronato, A. D’Odorico, and R. D’Incà. “Zinc Supplementation Tightens ‘Leaky Gut’ in Crohn’s Disease.” Inflammatory Bowel Diseases 7, no. 2 (May 2001): 94–98. https://www.ncbi.nlm.nih.gov/pubmed/11383597
52. Sommansson, Anna, Wan Salman Wan Saudi, Olof Nylander, and Markus Sjöblom. “Melatonin Inhibits Alcohol-Induced Increases in Duodenal Mucosal Permeability in Rats in Vivo.” American Journal of Physiology. Gastrointestinal and Liver Physiology 305, no. 1 (July 1, 2013): G95–105. doi:10.1152/ajpgi.00074.2013. https://www.ncbi.nlm.nih.gov/pubmed/?term=hcl+leaky+gut
53. Sun, Xuecheng, Yingying Shao, Yin Jin, Jiaping Huai, Qiong Zhou, Zhiming Huang, and Jiansheng Wu. “Melatonin Reduces Bacterial Translocation by Preventing Damage to the Intestinal Mucosa in an Experimental Severe Acute Pancreatitis Rat Model.” Experimental and Therapeutic Medicine 6, no. 6 (December 2013): 1343–49. doi:10.3892/etm.2013.1338. https://www.ncbi.nlm.nih.gov/pubmed/24255660
54. Mei, Qiao, Lei Diao, Jian-ming Xu, Xiao-chang Liu, and Juan Jin. “A Protective Effect of Melatonin on Intestinal Permeability Is Induced by Diclofenac via Regulation of Mitochondrial Function in Mice.” Acta Pharmacologica Sinica 32, no. 4 (April 2011): 495–502. doi:10.1038/aps.2010.225. https://www.ncbi.nlm.nih.gov/pubmed/21441945
55. Wang, Jing-Hua, Shambhunath Bose, Gi-Cheol Kim, Seung-Ug Hong, Ji-Hun Kim, Jai-Eun Kim, and Hojun Kim. “Flos Lonicera Ameliorates Obesity and Associated Endotoxemia in Rats through Modulation of Gut Permeability and Intestinal Microbiota.” PloS One 9, no. 1 (2014): e86117. doi:10.1371/journal.pone.0086117. https://www.ncbi.nlm.nih.gov/pubmed/24475077
56. Rapin, Jean Robert, and Nicolas Wiernsperger. “Possible Links between Intestinal Permeability and Food Processing: A Potential Therapeutic Niche for Glutamine.” Clinics (São Paulo, Brazil) 65, no. 6 (June 2010): 635–43. doi:10.1590/S1807-59322010000600012.
57. Berginc, Katja, Nataša Skalko-Basnet, Purusotam Basnet, and Albin Kristl. “Development and Evaluation of an in Vitro Vaginal Model for Assessment of Drug’s Biopharmaceutical Properties: Curcumin.” AAPS PharmSciTech 13, no. 4 (December 2012): 1045–53. doi:10.1208/s12249-012-9837-9. https://www.ncbi.nlm.nih.gov/pubmed/22899381
58. Maseko, Tebo, Frank Rowland Dunshea, Kate Howell, Hyun-Jung Cho, Leni Rose Rivera, John Barton Furness, and Ken Ng. “Selenium-Enriched Agaricus Bisporus Mushroom Protects against Increase in Gut Permeability Ex Vivo and up-Regulates Glutathione Peroxidase 1 and 2 in Hyperthermally-Induced Oxidative Stress in Rats.” Nutrients 6, no. 6 (June 2014): 2478–92. doi:10.3390/nu6062478. https://www.ncbi.nlm.nih.gov/pubmed/24962481
59. Ukena, Sya N., Anurag Singh, Ulrike Dringenberg, Regina Engelhardt, Ursula Seidler, Wiebke Hansen, André Bleich, et al. “Probiotic Escherichia Coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity.” PLoS ONE 2, no. 12 (December 12, 2007). doi:10.1371/journal.pone.0001308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110898/
60. Gnädinger, M. P., F. Eigenmann, A. Bekier, and R. L. Galeazzi. “[Pseudopancreatitis in entero-invasive salmonellosis].” Schweizerische Medizinische Wochenschrift 123, no. 30 (July 31, 1993): 1482–86. https://www.ncbi.nlm.nih.gov/pubmed/7690154
61. Andonegui, Graciela, Kim Goring, Dan Liu, Donna-Marie McCafferty, and Brent W. Winston. “Characterization of S. Pneumoniae Pneumonia-Induced Multiple Organ Dysfunction Syndrome: An Experimental Mouse Model of Gram-Positive Sepsis.” Shock (Augusta, Ga.) 31, no. 4 (April 2009): 423–28. doi:10.1097/SHK.0b013e318188c273. https://www.ncbi.nlm.nih.gov/pubmed/18827750
62. Maes, Michael, Marta Kubera, Jean-Claude Leunis, and Michael Berk. “Increased IgA and IgM Responses against Gut Commensals in Chronic Depression: Further Evidence for Increased Bacterial Translocation or Leaky Gut.” Journal of Affective Disorders 141, no. 1 (December 1, 2012): 55–62. doi:10.1016/j.jad.2012.02.023. https://www.ncbi.nlm.nih.gov/pubmed/22410503
63. Jung, Camille, Jean-Pierre Hugot, Frederick Barreau. “Peyer’s Patches: The Immune Sensors of the Intestine.” International Journal of Inflammation 2010 (September 19, 2010): e823710. doi:10.4061/2010/823710. https://www.hindawi.com/journals/iji/2010/823710/
64. Zanardi, I., S. Burgassi, E. Paccagnini, M. Gentile, V. Bocci, and V. Travagli. “What Is the Best Strategy for Enhancing the Effects of Topically Applied Ozonated Oils in Cutaneous Infections?” BioMed Research International 2013 (2013). doi:10.1155/2013/702949. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825054/
65. Bilia, Anna Rita, Francesca Santomauro, Cristiana Sacco, Maria Camilla Bergonzi, and Rosa Donato. “Essential Oil of Artemisia Annua L.: An Extraordinary Component with Numerous Antimicrobial Properties.” Evidence-Based Complementary and Alternative Medicine: eCAM 2014 (2014): 159819. doi:10.1155/2014/159819. https://www.ncbi.nlm.nih.gov/pubmed/24799936
66. Islamuddin, Mohammad, Garima Chouhan, Maujiram Tyagi, Malik Z. Abdin, Dinkar Sahal, and Farhat Afrin. “Leishmanicidal Activities of Artemisia Annua Leaf Essential Oil against Visceral Leishmaniasis.” Frontiers in Microbiology 5 (2014): 626. doi:10.3389/fmicb.2014.00626. https://www.ncbi.nlm.nih.gov/pubmed/25505453
67. Hammer, K. A., C. F. Carson, and T. V. Riley. “Antimicrobial Activity of Essential Oils and Other Plant Extracts.” Journal of Applied Microbiology 86, no. 6 (June 1999): 985–90. https://www.ncbi.nlm.nih.gov/pubmed/10438227
68. Briozzo, J., L. Núñez, J. Chirife, L. Herszage, and M. D’Aquino. “Antimicrobial Activity of Clove Oil Dispersed in a Concentrated Sugar Solution.” The Journal of Applied Bacteriology 66, no. 1 (January 1989): 69–75. https://www.ncbi.nlm.nih.gov/pubmed/2542213
69. Islamuddin, Mohammad, Dinkar Sahal, and Farhat Afrin. “Apoptosis-like Death in Leishmania Donovani Promastigotes Induced by Eugenol-Rich Oil of Syzygium Aromaticum.” Journal of Medical Microbiology 63, no. Pt 1 (January 2014): 74–85. doi:10.1099/jmm.0.064709-0. https://www.ncbi.nlm.nih.gov/pubmed/24161990
70. Machado, M., A. M. Dinis, L. Salgueiro, José B. A. Custódio, C. Cavaleiro, and M. C. Sousa. “Anti-Giardia Activity of Syzygium Aromaticum Essential Oil and Eugenol: Effects on Growth, Viability, Adherence and Ultrastructure.” Experimental Parasitology 127, no. 4 (April 2011): 732–39. doi:10.1016/j.exppara.2011.01.011. https://www.ncbi.nlm.nih.gov/pubmed/21272580
71. Karakuła-Juchnowicz, Hanna, Patrycja Szachta, Aneta Opolska, Justyna Morylowska-Topolska, Mirosława Gałęcka, Dariusz Juchnowicz, Paweł Krukow, and
Zofia Lasik. “The Role of IgG Hypersensitivity in the Pathogenesis and Therapy of Depressive Disorders.” Nutritional Neuroscience, September 30, 2014. doi:10.1179/1476830514Y.0000000158. https://www.ncbi.nlm.nih.gov/pubmed/25268936
72. Lerner, Aaron, and Torsten Matthias. “Changes in Intestinal Tight Junction Permeability Associated with Industrial Food Additives Explain the Rising Incidence of Autoimmune Disease.” Autoimmunity Reviews, February 9, 2015. doi:10.1016/j.autrev.2015.01.009. https://www.ncbi.nlm.nih.gov/pubmed/25676324
73. Sequeira, Ivana R., Marlena C. Kruger, Roger D. Hurst, and Roger G. Lentle. “Ascorbic Acid May Exacerbate Aspirin-Induced Increase in Intestinal Permeability.” Basic & Clinical Pharmacology & Toxicology, February 1, 2015. doi:10.1111/bcpt.12388. https://www.ncbi.nlm.nih.gov/pubmed/25641731
74. Elamin, Elhaseen, Ad Masclee, Freddy Troost, Harm-Jan Pieters, Daniel Keszthelyi, Katarina Aleksa, Jan Dekker, and Daisy Jonkers. “Ethanol Impairs Intestinal Barrier Function in Humans through Mitogen Activated Protein Kinase Signaling: A Combined in Vivo and in Vitro Approach.” PloS One 9, no. 9 (2014): e107421. doi:10.1371/journal.pone.0107421. https://www.ncbi.nlm.nih.gov/pubmed/25226407
75. Haroon, Ebrahim, Charles L Raison, and Andrew H Miller. “Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior.” Neuropsychopharmacology 37, no. 1 (January 2012): 137–62. doi:10.1038/npp.2011.205. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238082/
76. Mediterranean diet: A heart-healthy eating plan. Mayo Clinic. https://www.mayoclinic.org/healthy-living/nutrition-and-healthy-eating/in-depth/mediterranean-diet/art-20047801
77. Richard, Caroline, Patrick Couture, Sophie Desroches, and Benoît Lamarche. “Effect of the Mediterranean Diet with and without Weight Loss on Markers of Inflammation in Men with Metabolic Syndrome.” Obesity (Silver Spring, Md.) 21, no. 1 (January 2013): 51–57. doi:10.1002/oby.20239. https://www.ncbi.nlm.nih.gov/pubmed/23505168
2. Del Piano, Mario, Marco Balzarini, Stefania Carmagnola, Michela Pagliarulo, Roberto Tari, Stefania Nicola, Francesca Deidda, and Marco Pane. “Assessment of the Capability of a Gelling Complex Made of Tara Gum and the Exopolysaccharides Produced by the Microorganism Streptococcus Thermophilus ST10 to Prospectively Restore the Gut Physiological Barrier: A Pilot Study.” Journal of Clinical Gastroenterology 48 Suppl 1 (December 2014): S56–61. doi:10.1097/MCG.0000000000000254. https://www.ncbi.nlm.nih.gov/pubmed/25291130
3. Ilan Y. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18(21): 2609-2618 Available from: URL: https://www.wjgnet.com/1007-9327/full/v18/i21/2609.htm DOI: https://dx.doi.org/10.3748/wjg.v18.i21.2609 https://www.wjgnet.com/1007-9327/pdf/v18/i21/2609.pdf
4. Samsam M, Ahangari R, Naser SA. Pathophysiology of autism spectrum disorders:
revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol. 2014 Aug 7;20(29):9942-51. doi: 10.3748/wjg.v20.i29.9942. https://www.ncbi.nlm.nih.gov/pubmed/25110424
5. Wyatt, D. Leaky Gut Syndrome: Modern Epidemic with an Ancient Solution? Townshend Letter. June 2014. https://www.townsendletter.com/June2014/leaky0614.html
6. Mezzelani A, Raggi ME, Marabotti A, Milanesi L. Ochratoxin A as possible factor trigging autism and its male prevalence via epigenetic mechanism. Nutr Neurosci. 2015 Jan 17. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/25597866
7. Kennedy, Paul J, John F Cryan, Timothy G Dinan, and Gerard Clarke. “Irritable Bowel Syndrome: A Microbiome-Gut-Brain Axis Disorder?” World Journal of Gastroenterology : WJG 20, no. 39 (October 21, 2014): 14105–25. doi:10.3748/wjg.v20.i39.14105. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202342/
8. Del Piano, Mario, Marco Balzarini, Stefania Carmagnola, Michela Pagliarulo, Roberto Tari, Stefania Nicola, Francesca Deidda, and Marco Pane. “Assessment of the Capability of a Gelling Complex Made of Tara Gum and the Exopolysaccharides Produced by the Microorganism Streptococcus Thermophilus ST10 to Prospectively Restore the Gut Physiological Barrier: A Pilot Study.” Journal of Clinical Gastroenterology 48 Suppl 1 (December 2014): S56–61. doi:10.1097/MCG.0000000000000254. https://www.ncbi.nlm.nih.gov/pubmed/25291130
9. Rapin, Jean Robert, and Nicolas Wiernsperger. “Possible Links between Intestinal Permeability and Food Processing: A Potential Therapeutic Niche for Glutamine.” Clinics (São Paulo, Brazil) 65, no. 6 (June 2010): 635–43. doi:10.1590/S1807-59322010000600012. https://www.ncbi.nlm.nih.gov/pubmed/20613941
10. Orchard, Timothy R. “Management of Arthritis in Patients with Inflammatory Bowel Disease.” Gastroenterology & Hepatology 8, no. 5 (May 2012): 327–29. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424429/
11. van Hemert S, Breedveld AC, Rovers JM, Vermeiden JP, Witteman BJ, Smits MG, de Roos NM. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Front Neurol. 2014 Nov 21;5:241. doi: 10.3389/fneur.2014.00241. eCollection 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240046/
12. Karakuła-Juchnowicz H, Szachta P, Opolska A, Morylowska-Topolska J, Gałęcka M, Juchnowicz D, Krukow P, Lasik Z. The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders. Nutr Neurosci. 2014 Sep 30. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/25268936
13. Shoemaker, R. The Biotioxin Pathway. https://www.survivingmold.com/diagnosis/the-biotoxin-pathway
14. Glickstein L, Moore B, Bledsoe T, Damle N, Sikand V, Steere AC. Inflammatory Cytokine Production Predominates in Early Lyme Disease in Patients with Erythema Migrans . Infection and Immunity. 2003;71(10):6051-6053. doi:10.1128/IAI.71.10.6051-6053.2003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201073/
15. Buhner, Stephen H., Healing Lyme Disease Coinfections, Complementary and Holistic Treatments for Bartonella and Mycoplasma. Rochester: Healing Arts Press. 2013. Print. p. 342.
16. Hemmer RM, Ferrick DA, Conrad PA. Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1. Parasitol Res. 2000 Feb;86(2):121-8. https://www.ncbi.nlm.nih.gov/pubmed/10685843
17. Gong W, Xiong X, Qi Y, Jiao J, Duan C, Wen B. Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice. Vaccine. 2014 Apr 11;32(18):2027-33. doi: 10.1016/j.vaccine.2014.02.057. Epub 2014 Feb 28. https://www.ncbi.nlm.nih.gov/pubmed/24582636
18. Ismail N, Walker DH, Ghose P, Tang YW. Immune mediators of protective and pathogenic immune responses in patients with mild and fatal human monocytotropic ehrlichiosis. BMC Immunol. 2012 May 21;13:26. doi: 10.1186/1471-2172-13-26. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517396/
19. Feldman KE, Loriaux PM, Saito M, Tuero I, Villaverde H, Siva T, Gotuzzo E, Gilman RH, Hoffmann A, Vinetz JM. Ex vivo innate immune cytokine signature of enhanced risk of relapsing brucellosis. PLoS Negl Trop Dis. 2013 Sep 5;7(9):e2424. doi: 10.1371/journal.pntd.0002424. eCollection 2013. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764229/
20. Odenwald MA, Turner JR. Intestinal permeability defects: Is it time to treat? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2013;11(9):1075-1083. doi:10.1016/j.cgh.2013.07.001. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758766/
21. Shin HS1, Bae MJ1, Jung SY1, Shon DH2. Preventive effects of skullcap (Scutellaria baicalensis) extract in a mouse model of food allergy. J Ethnopharmacol. 2014 May 14;153(3):667-73. doi: 10.1016/j.jep.2014.03.018. Epub 2014 Mar 15. https://www.ncbi.nlm.nih.gov/pubmed/24637193
22. Woo et al., “Differential Inhibitory Effects of Baicalein and Baicalin on LPS-Induced Cyclooxygenase-2 Expression through Inhibition of C/EBPbeta DNA-Binding Activity.” Immunobiology. 2006;211(5):359-68. Epub 2006 Mar 29. https://www.ncbi.nlm.nih.gov/pubmed/16716805
23. Kim, Jin A., Arulkumar Nagappan, Hyeon Soo Park, Venu Venkatarame Gowda Saralamma, Gyeong Eun Hong, Silvia Yumnam, Ho Jeong Lee, et al. “Proteome Profiling of Lipopolysaccharide Induced L6 Rat Skeletal Muscle Cells Response to Flavonoids from Scutellaria Baicalensis Georgi.” BMC Complementary and Alternative Medicine 14 (2014): 379. doi:10.1186/1472-6882-14-379. https://www.ncbi.nlm.nih.gov/pubmed/25287937
24. Huang, Guan-Cheng, Jyh-Ming Chow, Shing-Chuan Shen, Liang-Yo Yang, Cheng-Wei Lin, and Yen-Chou Chen. “Wogonin but Not Nor-Wogonin Inhibits Lipopolysaccharide and Lipoteichoic Acid-Induced iNOS Gene Expression and NO Production in Macrophages.” International Immunopharmacology 7, no. 8 (August 2007): 1054–63. doi:10.1016/j.intimp.2007.04.001. https://www.ncbi.nlm.nih.gov/pubmed/17570322
25. Yang, Yao-Zhi, You-Zhi Tang, and Ya-Hong Liu. “Wogonoside Displays Anti-Inflammatory Effects through Modulating Inflammatory Mediator Expression Using RAW264.7 Cells.” Journal of Ethnopharmacology 148, no. 1 (June 21, 2013): 271–76. doi:10.1016/j.jep.2013.04.025. https://www.ncbi.nlm.nih.gov/pubmed/23612420
26. Mabalirajan, Ulaganathan, Tanveer Ahmad, Rakhshinda Rehman, Geeta Devi Leishangthem, Amit Kumar Dinda, Anurag Agrawal, Balaram Ghosh, and Surendra Kumar Sharma. “Baicalein Reduces Airway Injury in Allergen and IL-13 Induced Airway Inflammation.” PloS One 8, no. 4 (2013): e62916. doi:10.1371/journal.pone.0062916. https://www.ncbi.nlm.nih.gov/pubmed/23646158
27. Shin, Hee Soon, Min-Jung Bae, Sun Young Jung, and Dong-Hwa Shon. “Preventive Effects of Skullcap (Scutellaria Baicalensis) Extract in a Mouse Model of Food Allergy.” Journal of Ethnopharmacology 153, no. 3 (May 14, 2014): 667–73.
doi:10.1016/j.jep.2014.03.018. https://www.ncbi.nlm.nih.gov/pubmed/24637193
28. Kong, Song-Zhi, Hai-Ming Chen, Xiu-Ting Yu, Xie Zhang, Xue-Xuan Feng, Xin-Huang Kang, Wen-Jie Li, Na Huang, Hui Luo, and Zi-Ren Su. “The Protective Effect of 18β-Glycyrrhetinic Acid against UV Irradiation Induced Photoaging in Mice.” Experimental Gerontology 61 (January 2015): 147–55. doi:10.1016/j.exger.2014.12.008. https://www.ncbi.nlm.nih.gov/pubmed/25498537
29. Liu, Zhao, Ju-Ying Zhong, Er-Ning Gao, and Hong Yang. “[Effects of glycyrrhizin acid and licorice flavonoids on LPS-induced cytokines expression in macrophage].” Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica 39, no. 19 (October 2014): 3841–45. https://www.ncbi.nlm.nih.gov/pubmed/25612451
30. Fontes, Lívia Beatriz Almeida, Débora Dos Santos Dias, Lara Soares Aleixo de Carvalho, Harleson Lopes Mesquita, Lívia da Silva Reis, Alyria Teixeira Dias, Ademar A. Da Silva Filho, and José Otávio do Amaral Corrêa. “Immunomodulatory Effects of Licochalcone A on Experimental Autoimmune Encephalomyelitis.” The Journal of Pharmacy and Pharmacology 66, no. 6 (June 2014): 886–94. doi:10.1111/jphp.12212. https://www.ncbi.nlm.nih.gov/pubmed/24447171
31. “Deglycyrrhizinated Licorice (DGL): Gut Benefits and Beyond.” The Huffington Post. Accessed March 17, 2015. https://www.huffingtonpost.com/julie-chen-md/dgl-supplements_b_2976260.html.
32. Chen, John K., and Tina T. Chen. 2004. Chinese Medical Herbology and Pharmacology. City of Industry CA: Art of Medicine Press, Inc., pp. 999 – 1001.
33. Cao, Gui-Yun, Xiu-Wei Yang, Wei Xu, and Fei Li. “New Inhibitors of Nitric Oxide Production from the Seeds of Myristica Fragrans.” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 62 (December 2013): 167–71. doi:10.1016/j.fct.2013.08.046. https://www.ncbi.nlm.nih.gov/pubmed/23994084
34. Kang, Jungwon, Nara Tae, Byung Sun Min, Jongseon Choe, and Jeong-Hyung Lee. “Malabaricone C Suppresses Lipopolysaccharide-Induced Inflammatory Responses via Inhibiting ROS-Mediated Akt/IKK/NF-κB Signaling in Murine Macrophages.” International Immunopharmacology 14, no. 3 (November 2012): 302–10. doi:10.1016/j.intimp.2012.08.006. https://www.ncbi.nlm.nih.gov/pubmed/22917708
35. Han, Young Sun, Myung-Suk Kim, and Jae-Kwan Hwang. “Macelignan Inhibits Histamine Release and Inflammatory Mediator Production in Activated Rat Basophilic Leukemia Mast Cells.” Inflammation 35, no. 5 (October 2012): 1723–31. doi:10.1007/s10753-012-9490-1. https://www.ncbi.nlm.nih.gov/pubmed/19483320
36. Han YS, Kim MS, Hwang JK. Macelignan inhibits histamine release and inflammatory mediator production in activated rat basophilic leukemia mast cells. Inflammation. 2012 Oct;35(5):1723-31. doi: 10.1007/s10753-012-9490-1. https://www.ncbi.nlm.nih.gov/pubmed/22729280
37. Baker, J., K. Brown, E. Rajendiran, A. Yip, D. DeCoffe, C. Dai, E. Molcan, et al. “Medicinal Lavender Modulates the Enteric Microbiota to Protect against Citrobacter Rodentium-Induced Colitis.” American Journal of Physiology. Gastrointestinal and Liver Physiology 303, no. 7 (October 2012): G825–36. doi:10.1152/ajpgi.00327.2011. https://www.ncbi.nlm.nih.gov/pubmed/22821949
38. Ueno-Iio, Tomoe, Misako Shibakura, Kanayo Yokota, Michinori Aoe, Tomoko Hyoda, Ryoko Shinohata, Arihiko Kanehiro, Mitsune Tanimoto, and Mikio Kataoka. “Lavender Essential Oil Inhalation Suppresses Allergic Airway Inflammation and Mucous Cell Hyperplasia in a Murine Model of Asthma.” Life Sciences 108, no. 2 (July 17, 2014):
109–15. doi:10.1016/j.lfs.2014.05.018. https://www.ncbi.nlm.nih.gov/pubmed/24909715
39. Huang, Mei-Yu, May-Hua Liao, Yang-Kao Wang, Yung-Sheng Huang, and Hsiao-Chuan Wen. “Effect of Lavender Essential Oil on LPS-Stimulated Inflammation.” The American Journal of Chinese Medicine 40, no. 4 (2012): 845–59. doi:10.1142/S0192415X12500632. https://www.ncbi.nlm.nih.gov/pubmed/22809036
40. McMakin C. Frequency Specific Microcurrent in Pain Management. Edinburgh: Churchill Livingstone/Elsevier; 2011.
41. Barbara, Giovanni, Lisa Zecchi, Raffaella Barbaro, Cesare Cremon, Lara Bellacosa, Marco Marcellini, Roberto De Giorgio, Roberto Corinaldesi, and Vincenzo Stanghellini. “Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome.” Journal of Clinical Gastroenterology 46 Suppl (October 2012): S52–55. doi:10.1097/MCG.0b013e318264e918. https://www.ncbi.nlm.nih.gov/pubmed/22955358
42. Ukena, Sya N., Anurag Singh, Ulrike Dringenberg, Regina Engelhardt, Ursula Seidler, Wiebke Hansen, André Bleich, et al. “Probiotic Escherichia Coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity.” PLoS ONE 2, no. 12 (December 12, 2007). doi:10.1371/journal.pone.0001308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110898/
43. Ait-Belgnaoui, Afifa, Henri Durand, Christel Cartier, Gilles Chaumaz, Hélène Eutamene, Laurent Ferrier, Eric Houdeau, Jean Fioramonti, Lionel Bueno, and Vassilia Theodorou. “Prevention of Gut Leakiness by a Probiotic Treatment Leads to Attenuated HPA Response to an Acute Psychological Stress in Rats.” Psychoneuroendocrinology 37, no. 11 (November 2012): 1885–95. doi:10.1016/j.psyneuen.2012.03.024. https://www.ncbi.nlm.nih.gov/pubmed/22541937
44. Bodera, Pawel. “Influence of Prebiotics on the Human Immune System (GALT).” Recent Patents on Inflammation & Allergy Drug Discovery 2, no. 2 (June 2008): 149–53. https://www.ncbi.nlm.nih.gov/pubmed/19076004
45 Robinson, R. R., J. Feirtag, and J. L. Slavin. “Effects of Dietary Arabinogalactan on Gastrointestinal and Blood Parameters in Healthy Human Subjects.” Journal of the American College of Nutrition 20, no. 4 (August 2001): 279–85. https://www.ncbi.nlm.nih.gov/pubmed/11506055
46. Rapin, Jean Robert, and Nicolas Wiernsperger. “Possible Links between Intestinal Permeability and Food Processing: A Potential Therapeutic Niche for Glutamine.” Clinics (São Paulo, Brazil) 65, no. 6 (June 2010): 635–43. doi:10.1590/S1807-59322010000600012. https://www.ncbi.nlm.nih.gov/pubmed/20613941
47. Wang, Hao, Chen Zhang, Guoyao Wu, Yuli Sun, Bin Wang, Beibei He, Zhaolai Dai, and Zhenlong Wu. “Glutamine Enhances Tight Junction Protein Expression and Modulates Corticotropin-Releasing Factor Signaling in the Jejunum of Weanling Piglets.” The Journal of Nutrition 145, no. 1 (January 2015): 25–31. doi:10.3945/jn.114.202515. https://www.ncbi.nlm.nih.gov/pubmed/25527658
48. Peng, Zhanglong, Kechen Ban, Richard A. Wawrose, Adam G. Gover, and Rosemary A. Kozar. “Protection by Enteral Glutamine Is Mediated by Intestinal Epithelial Cell Peroxisome Proliferator-Activated Receptor-Γ During Intestinal Ischemia/Reperfusion.” Shock (Augusta, Ga.) 43, no. 4 (April 2015): 327–33. doi:10.1097/SHK.0000000000000297.
49. Beaufrère, A. M., N. Neveux, P. Patureau Mirand, C. Buffière, G. Marceau, V. Sapin, L. Cynober, and D. Meydinal-Denis. “Long-Term Intermittent Glutamine Supplementation Repairs Intestinal Damage (structure and Functional Mass) with Advanced Age: Assessment with Plasma Citrulline in a Rodent Model.” The Journal of Nutrition, Health
& Aging 18, no. 9 (November 2014): 814–19. doi:10.1007/s12603-014-0468-6. https://www.ncbi.nlm.nih.gov/pubmed/25389959
50. Maes, Michael, and Jean-Claude Leunis. “Normalization of Leaky Gut in Chronic Fatigue Syndrome (CFS) Is Accompanied by a Clinical Improvement: Effects of Age, Duration of Illness and the Translocation of LPS from Gram-Negative Bacteria.” Neuro Endocrinology Letters 29, no. 6 (December 2008): 902–10. https://www.ncbi.nlm.nih.gov/pubmed/19112401
51. Sturniolo, G. C., V. Di Leo, A. Ferronato, A. D’Odorico, and R. D’Incà. “Zinc Supplementation Tightens ‘Leaky Gut’ in Crohn’s Disease.” Inflammatory Bowel Diseases 7, no. 2 (May 2001): 94–98. https://www.ncbi.nlm.nih.gov/pubmed/11383597
52. Sommansson, Anna, Wan Salman Wan Saudi, Olof Nylander, and Markus Sjöblom. “Melatonin Inhibits Alcohol-Induced Increases in Duodenal Mucosal Permeability in Rats in Vivo.” American Journal of Physiology. Gastrointestinal and Liver Physiology 305, no. 1 (July 1, 2013): G95–105. doi:10.1152/ajpgi.00074.2013. https://www.ncbi.nlm.nih.gov/pubmed/?term=hcl+leaky+gut
53. Sun, Xuecheng, Yingying Shao, Yin Jin, Jiaping Huai, Qiong Zhou, Zhiming Huang, and Jiansheng Wu. “Melatonin Reduces Bacterial Translocation by Preventing Damage to the Intestinal Mucosa in an Experimental Severe Acute Pancreatitis Rat Model.” Experimental and Therapeutic Medicine 6, no. 6 (December 2013): 1343–49. doi:10.3892/etm.2013.1338. https://www.ncbi.nlm.nih.gov/pubmed/24255660
54. Mei, Qiao, Lei Diao, Jian-ming Xu, Xiao-chang Liu, and Juan Jin. “A Protective Effect of Melatonin on Intestinal Permeability Is Induced by Diclofenac via Regulation of Mitochondrial Function in Mice.” Acta Pharmacologica Sinica 32, no. 4 (April 2011): 495–502. doi:10.1038/aps.2010.225. https://www.ncbi.nlm.nih.gov/pubmed/21441945
55. Wang, Jing-Hua, Shambhunath Bose, Gi-Cheol Kim, Seung-Ug Hong, Ji-Hun Kim, Jai-Eun Kim, and Hojun Kim. “Flos Lonicera Ameliorates Obesity and Associated Endotoxemia in Rats through Modulation of Gut Permeability and Intestinal Microbiota.” PloS One 9, no. 1 (2014): e86117. doi:10.1371/journal.pone.0086117. https://www.ncbi.nlm.nih.gov/pubmed/24475077
56. Rapin, Jean Robert, and Nicolas Wiernsperger. “Possible Links between Intestinal Permeability and Food Processing: A Potential Therapeutic Niche for Glutamine.” Clinics (São Paulo, Brazil) 65, no. 6 (June 2010): 635–43. doi:10.1590/S1807-59322010000600012.
57. Berginc, Katja, Nataša Skalko-Basnet, Purusotam Basnet, and Albin Kristl. “Development and Evaluation of an in Vitro Vaginal Model for Assessment of Drug’s Biopharmaceutical Properties: Curcumin.” AAPS PharmSciTech 13, no. 4 (December 2012): 1045–53. doi:10.1208/s12249-012-9837-9. https://www.ncbi.nlm.nih.gov/pubmed/22899381
58. Maseko, Tebo, Frank Rowland Dunshea, Kate Howell, Hyun-Jung Cho, Leni Rose Rivera, John Barton Furness, and Ken Ng. “Selenium-Enriched Agaricus Bisporus Mushroom Protects against Increase in Gut Permeability Ex Vivo and up-Regulates Glutathione Peroxidase 1 and 2 in Hyperthermally-Induced Oxidative Stress in Rats.” Nutrients 6, no. 6 (June 2014): 2478–92. doi:10.3390/nu6062478. https://www.ncbi.nlm.nih.gov/pubmed/24962481
59. Ukena, Sya N., Anurag Singh, Ulrike Dringenberg, Regina Engelhardt, Ursula Seidler, Wiebke Hansen, André Bleich, et al. “Probiotic Escherichia Coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity.” PLoS ONE 2, no. 12 (December 12, 2007). doi:10.1371/journal.pone.0001308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110898/
60. Gnädinger, M. P., F. Eigenmann, A. Bekier, and R. L. Galeazzi. “[Pseudopancreatitis in entero-invasive salmonellosis].” Schweizerische Medizinische Wochenschrift 123, no. 30 (July 31, 1993): 1482–86. https://www.ncbi.nlm.nih.gov/pubmed/7690154
61. Andonegui, Graciela, Kim Goring, Dan Liu, Donna-Marie McCafferty, and Brent W. Winston. “Characterization of S. Pneumoniae Pneumonia-Induced Multiple Organ Dysfunction Syndrome: An Experimental Mouse Model of Gram-Positive Sepsis.” Shock (Augusta, Ga.) 31, no. 4 (April 2009): 423–28. doi:10.1097/SHK.0b013e318188c273. https://www.ncbi.nlm.nih.gov/pubmed/18827750
62. Maes, Michael, Marta Kubera, Jean-Claude Leunis, and Michael Berk. “Increased IgA and IgM Responses against Gut Commensals in Chronic Depression: Further Evidence for Increased Bacterial Translocation or Leaky Gut.” Journal of Affective Disorders 141, no. 1 (December 1, 2012): 55–62. doi:10.1016/j.jad.2012.02.023. https://www.ncbi.nlm.nih.gov/pubmed/22410503
63. Jung, Camille, Jean-Pierre Hugot, Frederick Barreau. “Peyer’s Patches: The Immune Sensors of the Intestine.” International Journal of Inflammation 2010 (September 19, 2010): e823710. doi:10.4061/2010/823710. https://www.hindawi.com/journals/iji/2010/823710/
64. Zanardi, I., S. Burgassi, E. Paccagnini, M. Gentile, V. Bocci, and V. Travagli. “What Is the Best Strategy for Enhancing the Effects of Topically Applied Ozonated Oils in Cutaneous Infections?” BioMed Research International 2013 (2013). doi:10.1155/2013/702949. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825054/
65. Bilia, Anna Rita, Francesca Santomauro, Cristiana Sacco, Maria Camilla Bergonzi, and Rosa Donato. “Essential Oil of Artemisia Annua L.: An Extraordinary Component with Numerous Antimicrobial Properties.” Evidence-Based Complementary and Alternative Medicine: eCAM 2014 (2014): 159819. doi:10.1155/2014/159819. https://www.ncbi.nlm.nih.gov/pubmed/24799936
66. Islamuddin, Mohammad, Garima Chouhan, Maujiram Tyagi, Malik Z. Abdin, Dinkar Sahal, and Farhat Afrin. “Leishmanicidal Activities of Artemisia Annua Leaf Essential Oil against Visceral Leishmaniasis.” Frontiers in Microbiology 5 (2014): 626. doi:10.3389/fmicb.2014.00626. https://www.ncbi.nlm.nih.gov/pubmed/25505453
67. Hammer, K. A., C. F. Carson, and T. V. Riley. “Antimicrobial Activity of Essential Oils and Other Plant Extracts.” Journal of Applied Microbiology 86, no. 6 (June 1999): 985–90. https://www.ncbi.nlm.nih.gov/pubmed/10438227
68. Briozzo, J., L. Núñez, J. Chirife, L. Herszage, and M. D’Aquino. “Antimicrobial Activity of Clove Oil Dispersed in a Concentrated Sugar Solution.” The Journal of Applied Bacteriology 66, no. 1 (January 1989): 69–75. https://www.ncbi.nlm.nih.gov/pubmed/2542213
69. Islamuddin, Mohammad, Dinkar Sahal, and Farhat Afrin. “Apoptosis-like Death in Leishmania Donovani Promastigotes Induced by Eugenol-Rich Oil of Syzygium Aromaticum.” Journal of Medical Microbiology 63, no. Pt 1 (January 2014): 74–85. doi:10.1099/jmm.0.064709-0. https://www.ncbi.nlm.nih.gov/pubmed/24161990
70. Machado, M., A. M. Dinis, L. Salgueiro, José B. A. Custódio, C. Cavaleiro, and M. C. Sousa. “Anti-Giardia Activity of Syzygium Aromaticum Essential Oil and Eugenol: Effects on Growth, Viability, Adherence and Ultrastructure.” Experimental Parasitology 127, no. 4 (April 2011): 732–39. doi:10.1016/j.exppara.2011.01.011. https://www.ncbi.nlm.nih.gov/pubmed/21272580
71. Karakuła-Juchnowicz, Hanna, Patrycja Szachta, Aneta Opolska, Justyna Morylowska-Topolska, Mirosława Gałęcka, Dariusz Juchnowicz, Paweł Krukow, and
Zofia Lasik. “The Role of IgG Hypersensitivity in the Pathogenesis and Therapy of Depressive Disorders.” Nutritional Neuroscience, September 30, 2014. doi:10.1179/1476830514Y.0000000158. https://www.ncbi.nlm.nih.gov/pubmed/25268936
72. Lerner, Aaron, and Torsten Matthias. “Changes in Intestinal Tight Junction Permeability Associated with Industrial Food Additives Explain the Rising Incidence of Autoimmune Disease.” Autoimmunity Reviews, February 9, 2015. doi:10.1016/j.autrev.2015.01.009. https://www.ncbi.nlm.nih.gov/pubmed/25676324
73. Sequeira, Ivana R., Marlena C. Kruger, Roger D. Hurst, and Roger G. Lentle. “Ascorbic Acid May Exacerbate Aspirin-Induced Increase in Intestinal Permeability.” Basic & Clinical Pharmacology & Toxicology, February 1, 2015. doi:10.1111/bcpt.12388. https://www.ncbi.nlm.nih.gov/pubmed/25641731
74. Elamin, Elhaseen, Ad Masclee, Freddy Troost, Harm-Jan Pieters, Daniel Keszthelyi, Katarina Aleksa, Jan Dekker, and Daisy Jonkers. “Ethanol Impairs Intestinal Barrier Function in Humans through Mitogen Activated Protein Kinase Signaling: A Combined in Vivo and in Vitro Approach.” PloS One 9, no. 9 (2014): e107421. doi:10.1371/journal.pone.0107421. https://www.ncbi.nlm.nih.gov/pubmed/25226407
75. Haroon, Ebrahim, Charles L Raison, and Andrew H Miller. “Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior.” Neuropsychopharmacology 37, no. 1 (January 2012): 137–62. doi:10.1038/npp.2011.205. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238082/
76. Mediterranean diet: A heart-healthy eating plan. Mayo Clinic. https://www.mayoclinic.org/healthy-living/nutrition-and-healthy-eating/in-depth/mediterranean-diet/art-20047801
77. Richard, Caroline, Patrick Couture, Sophie Desroches, and Benoît Lamarche. “Effect of the Mediterranean Diet with and without Weight Loss on Markers of Inflammation in Men with Metabolic Syndrome.” Obesity (Silver Spring, Md.) 21, no. 1 (January 2013): 51–57. doi:10.1002/oby.20239. https://www.ncbi.nlm.nih.gov/pubmed/23505168
Image courtesy of: By user:Pieter1 (Own work) [GFDL (https://www.gnu.org/copyleft/fdl.html), CC-BY-SA-3.0 (https://creativecommons.org/licenses/by-sa/3.0/) or CC BY-SA 2.5-2.0-1.0 (https://creativecommons.org/licenses/by-sa/2.5-2.0-1.0)], via Wikimedia Commons
Greg,
Great picture and even better article. I was planning on having a glass of wine tonight, I think I will take some melatonin afterwards now, too.
Ozonated oils: I would really like to start taking ozonated oils or water. I did IV ozone therapy and it work fantastically. Do you think the ozonated oils hold the ozone?
Hi Yessi, ozonated oils have excellent anti-microbial properties https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825054/
1st comment was accidentally sent so here is the COMPLETED VERSION.
I recently found out I had chronic Lyme (possibly over 16 years ago when diagnosed with lupus with a symptom-free 7 years in between then and now OR perhaps I got it when I moved to New England the last 4 yearsa). I also tested positive for Epstein Barr virus, mycoplasma pneumoniae, klebsiella, candida, leaky gut and heavy metals (lead and thallium on a 6 hr challenge test). Could you please share what would be a logical order to address these issues?
1. Of the conditions listed, is there one or 2 things that is a MUST to treat first before all the others such as candida and leaky gut first, metals second and then the pathogens OR do it all simultaneously? Is there one thing that should be addressed first before the others; otherwise, a person will continue to have a hindrance to healing?
2. Since one should ensure detox pathways are working properly, would a a a kidney and or liver cleanse be a good idea first as well before jumping into any treatment?
Hi Shari, I’m sorry to hear about your multiple infections and metals. It really depends up on which infection or metal is creating the biggest burden on your health. We use an electrodermal scan to prioritize treatment in patients similar to you. Depending upon the level of toxicity and inflammation in a patient, we will use gentle methods at first and then increase cleansing as needed.